Jeannette Nashed

发表

Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease.

S. Steinberg, L. Morton, E. Cowen, 2021, Transplantation and cellular therapy.

Efficacy and Safety of Baricitinib in Refractory Chronic Graft-Versus-Host Disease (cGVHD): Preliminary Analysis Results of a Phase 1/2 Study

W. Figg, A. Im, C. Peer, 2020 .